Eli Lilly will consider lower insulin prices, CEO says

Eli Lilly CEO David Ricks told CNBC June 29 that the drugmaker will look for new ways to cut insulin prices in the face of competition from Walmart, which launched its own private label insulin at nearly half the price of Eli Lilly's.